Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc.

AUPH | NASDAQ
Chart Builder DCF Calculator
$16.74
+$0.13 (+0.78%)
Sep 22, 2026, 12:46 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
80.21M 83.43M 48.88M 94.17M 231.9M 272.35M
Short-Term Investments
317.78M 275.04M 301.61M 295.22M 234.18M 125.98M
Long-Term Investments
n/a n/a 201K n/a n/a 24.38M
Other Long-Term Assets
93K 823K 1.52M 13.34M 11.84M 247K
Receivables
41.45M 36.54M 24.09M 13.48M 15.41M n/a
Inventory
45.69M 39.23M 39.71M 24.75M 19.33M 13.93M
Other Current Assets
1.08M 1.13M 1.03M 1.33M 796K 1.02M
Total Current Assets
491.97M 446.6M 424.8M 442.54M 513.32M 419.43M
Property-Plant & Equipment
79.57M 98.87M 116.57M 8.56M 9.8M 10.28M
Goodwill & Intangibles
3.76M 4.36M 4.98M 6.43M 8.4M 9.33M
Total Long-Term Assets
259.62M 104.05M 123.26M 28.32M 30.04M 44.23M
Total Assets
751.59M 550.65M 548.06M 470.86M 543.37M 463.66M
Account Payables
3.31M 5.19M 4.33M 3.09M 3.88M 2.64M
Deferred Revenue
3.72M 11M 4.81M 3.15M 190K n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a
Other Current Liabilities
2.48M 1.53M 1.59M 2.03M 4.45M 6.41M
Total Current Liabilities
93.72M 97.76M 77.19M 46.11M 40.65M 32M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
6.66M 11.11M 10.91M 12.17M 15.95M 16.3M
Total Long-Term Liabilities
76.53M 75.4M 92.92M 19.32M 23.63M 23.91M
Total Liabilities
170.26M 173.17M 170.11M 65.43M 64.28M 55.91M
Total Debt
74.81M 79.37M 97.61M 8.09M 8.74M 8.41M
Book Value
581.33M 377.48M 377.95M 405.44M 479.09M 407.75M
Book Value Per Share
4.19 2.58 2.64 2.86 3.70 3.44
Common Stock
1.12B 1.19B 1.2B 1.19B 1.18B 944.33M
Retained Earnings
-649.37M -936.57M -942.32M -864.3M -756.12M -575.16M
Comprehensive Income
-599K -647K -730K -1.06M -852K -805K
Shareholders Equity
581.33M 377.48M 377.95M 405.44M 479.09M 407.75M
Total Investments
317.78M 275.04M 301.82M 295.22M 234.18M 150.36M

© 2026 bestshares.com. All rights reserved.